Addressing the Growing Epidemic of Opiate Addiction

Teenage Girl Buying Drugs On The Street From Dealer

(DGIwire) — Addiction to painkillers, both prescription and recreational, has reached epidemic proportions. According to a recent article in TIME magazine, the city of Chicago has filed a lawsuit against five different pharmaceutical companies, alleging that they deceptively marketed opioid painkillers such as Percocet and OxyContin for chronic pain management, even though the companies knew the drugs were ineffective at treating chronic pain and carried a high risk of addiction. The article detailed how these deceptive marketing practices have caused health problems in Chicago in recent years, reporting that opioid misuse resulted in more than 1,000 emergency room visits in Chicago in 2009 alone.

These astronomical numbers are not unique to Chicago. According to the 2012 National Survey on Drug Use and Health, conducted by the U.S. Department of Health and Human Services, two and a half million people are dependent on prescription opioids. Prescription opioid addiction is also a complex, multifaceted socioeconomic problem. A recent analysis from JAMA Psychiatry showed that prescription drug abuse has become a gateway for heroin use. What was once a problem mainly among urban youth has now become increasingly epidemic among older suburbanites.

While Chicago and other cities have made it their goal to work from the top down to solve opioid addiction, one company has decided to make it its mission to work on the ground floor, treating those who are currently struggling with dependency. BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company based in Raleigh, NC, is dedicated to treating addiction while providing new methods for pain management. BDSI understands that drug addiction is a complicated medical problem requiring long-term treatment and care, and is focused on helping people living with addiction to regain control of their lives.

Dr. Mark Sirgo, CEO of BDSI says, “Opioids have been effectively treating pain for hundreds of years. What patients and their caregivers need is effective pain relief while limiting the potential for abuse and possibly addiction.”

Helping patients stay with their therapy may help to improve their chances of success, and BDSI is dedicated to this noble goal. Learn more at bdsi.com or twitter.com/BioDeliverySI

close